Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma

Elizabeth B Lamont, MD MS, MMSc, Andrew J. Yee, MD, Stuart L. Goldberg, MD, Andrew D Norden, MD MPH, MBA

Blood (2019) 134 (Supplement_1): 2193.

https://doi.org/10.1182/blood-2019-125407

Published: 2019

Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Blood (2019) 134 (Supplement_1): 494.

https://doi.org/10.1182/blood-2019-123674

Published: 2019

Journal Articles

Regression of Epithelial Cancers Following T Cell Receptor Gene Therapy Targeting Human Papillomavirus-16 E7

Scott Michael Norberg, DO, Nisha Nagarsheth, PhD, Stacey Doran, MD, Jennifer A Kanakry, MD, Sabina Adhikary, PhD, Colleen Schweitzer, PhD, Stephanie H Astrow, PhD, William Faquin, MD, Nikolaos Gkitsas, Steven Highfill, PhD, Christian S Hinrichs

Blood (2018) 132 (Supplement 1): 492.

https://doi.org/10.1182/blood-2018-99-117017

Published: 2018

Journal Articles

Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial

Blood (2017) 130 (Supplement 1): 899.

https://doi.org/10.1182/blood.V130.Suppl_1.899.899

Published: 2017

Journal Articles

Secondary Solid Cancer Following Hematopoietic Cell Transplantation in Patients with Thalassemia Major

Alessia Pepe, MD, Antonella Meloni, PhD, Stella Santarone, Annalisa Natale, Mauro Di Ianni, MD PhD, Laura Pistoia, MD, Liana Cuccia, MD, Anna Spasiano, Roberto Lisi, Paolo Di Bartolomeo, MD

Blood (2017) 130 (Supplement 1): 3274.

https://doi.org/10.1182/blood.V130.Suppl_1.3274.3274

Published: 2017

Journal Articles

Cancer in the National Cancer Institute Inherited Bone Marrow Failure Syndrome Cohort after 15 Years of Follow-up

Blanche P Alter, MD MPH, Neelam Giri, MD, Sharon A Savage, MD, Philip S. Rosenberg, PhD

Blood (2016) 128 (22): 334.

https://doi.org/10.1182/blood.V128.22.334.334

Published: 2016

Journal Articles

Anti-Cancer Effects of Clofazimine As a Single Agent and in Combination with Cisplatin in Multiple Myeloma

Ipek Durusu, PhD, Hazal Hepsen Husnugil, Heval Atas, Aysenur Biber, Selin Gerekci, Aliye Ezgi Gulec, Can Ozen, Assoc. Prof.

Blood (2016) 128 (22): 5897.

https://doi.org/10.1182/blood.V128.22.5897.5897

Published: 2016

Journal Articles

Risk for New Malignancies of Potential Infectious Etiology Among Adult Survivors of Specific Non-Hodgkin Lymphoma Subtypes

Megan M Herr, PhD, Sara J. Schonfeld, PhD, Graca M. Dores, MD MPH, Margaret A. Tucker, MD, Rochelle E Curtis, MA, Lindsay M Morton, PhD

Blood (2016) 128 (22): 2414.

https://doi.org/10.1182/blood.V128.22.2414.2414

Published: 2016

Journal Articles

Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012

Lindsay M Morton, PhD, Graca M. Dores, MD MPH, Meredith S Shiels, PhD, Martha S Linet, MD MPH, Jop C Teepen, Clara J.K. Lam, PhD, Margaret A. Tucker, MD, Rochelle E Curtis, MA

Blood (2015) 126 (23): 562.

https://doi.org/10.1182/blood.V126.23.562.562

Published: 2015

Journal Articles

Rare Presentation of Relapsed Extranasal Natural Killer/T Cell Leukemia Lymphoma Involving the Hypothalamus

Byung Moon Kim, MD, Mohsin Malik, MD MBBS, Todd F. Roberts, MD MSC, FRCP (C)

Blood (2015) 126 (23): 5012.

https://doi.org/10.1182/blood.V126.23.5012.5012

Published: 2015

Journal Articles

National Epidemiology of Venous Thromboembolism in Patients with Malignancy in United States from 1993 to 2012

Kathan Dilipbhai Mehta, MBBS, MPH, Leonard Appleman, MDPhD, Hong Wang, PhD, Roy E. Smith, MD, Rahul Atul Parikh, MD PhD

Blood (2015) 126 (23): 2060.

https://doi.org/10.1182/blood.V126.23.2060.2060

Published: 2015

Journal Articles

Prediagnostic Thrombocytosis Increases the Risk of Advanced Gynecological Cancer and Increases Mortality Independently of Cancer Stage – a Population-Based Study

Christen Lykkegaard Andersen, MD, Volkert Siersma, MSc, Hans Carl Hasselbalch, MD PhD, Ole Weis Bjerrum, MD, Peter Felding, MD, Bent Lind, MD, Jan Palmblad, MD PhD, Niels de Fine Olivarius, MD

Blood (2014) 124 (21): 2791.

https://doi.org/10.1182/blood.V124.21.2791.2791

Published: 2014

Journal Articles

Stem Cell Paradigms in Tissue Regeneration and Cancer

Elaine Fuchs, PhD

Blood (2014) 124 (21): SCI-41.

https://doi.org/10.1182/blood.V124.21.SCI-41.SCI-41

Published: 2014

Journal Articles

Efficacy and Safety of IV Ferumoxytol (FER) for Iron Deficiency Anemia (IDA) in Patients with Cancer

Saroj Vadhan-Raj, MD, Naomi V. Dahl, Pharm D, Kristine Bernard, MPH, Zhu Li, PhD, William Strauss, MD, F.A.C.C.

Blood (2014) 124 (21): 1352.

https://doi.org/10.1182/blood.V124.21.1352.1352

Published: 2014

Journal Articles

Primary Granulocytic Sarcoma of Cervix (PGSC): Review and Analysis of 13 Cases

Xuelan Zuo, Ying Wang, Yi Zhou, Lin Luo, Minghui Liu

Blood (2014) 124 (21): 5271.

https://doi.org/10.1182/blood.V124.21.5271.5271

Published: 2014

Journal Articles

Advanced Age at Transplant Increases the Risk of Second Solid Malignancy (SSM) after Haematopoetic Stem Cell Transplantation (HSCT)

John Murray, RGN, MSc, John Chadwick, MRCP, Adrian Bloor, PhD FRCPath, Jim Cavet, FRCPath, Mike Dennis, FRCPath, Tim Somervaille, FRCPath, Sven Armin Sommerfeld, MRCP, John Eliott, MRCP, Siobhan Muthia, MRCP, Angie Leather, RGN BSc, Rita Angelica, RGN BSc, Rachel Brown, MRCP, Jo Tomlins, MSc, Samar Kulkarni, FRCPath

Blood (2014) 124 (21): 3952.

https://doi.org/10.1182/blood.V124.21.3952.3952

Published: 2014

Journal Articles

Autoimmune Hemolytic Anemia In Cancer Patients At a Tertiary Center In Southern Nigeria

Kaladada I. Korubo, MBBS, FMCPATH, Chijioke A. Nwauche, MBBS, FWACP, Oseikhuemen A. Ejele, MBBS, FWACP, FMCPATH

Blood (2013) 122 (21): 4658.

https://doi.org/10.1182/blood.V122.21.4658.4658

Published: 2013

Journal Articles

Expression Patterns Of NBEAL2 In Human Tissues and a Megakaryocytic Cell Line

Leila Noetzli, BS, Natalie Smith, BS, Gary Brodsky, PhD, Jorge Di Paola, MD

Blood (2013) 122 (21): 1075.

https://doi.org/10.1182/blood.V122.21.1075.1075

Published: 2013

Journal Articles

The Hemostasis and Thrombosis Research Society (HTRS) Registry Study of Acquired Hemophilia: Assessment of AH Patient Demographics in the US

Craig M. Kessler, MD, Alice D. Ma, MD, Hamid A B Al-Mondhiry, MD, Margaret Fisher, PharmD, Robert Z. Gut, MD, PhD, David L. Cooper, MD, MBA

Blood (2012) 120 (21): 4625.

https://doi.org/10.1182/blood.V120.21.4625.4625

Published: 2012

Journal Articles

Rates of Malposition and Expulsion of the Levonorgestrel-Releasing Intrauterine System Among Women with Inherited Bleeding Disorders

Emily K. Rimmer, MD, Mary Anne Jamieson, MD, Paula D. James, MD

Blood (2012) 120 (21): 3367.

https://doi.org/10.1182/blood.V120.21.3367.3367

Published: 2012

NARROW

Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Regression of Epithelial Cancers Following T Cell Receptor Gene Therapy Targeting Human Papillomavirus-16 E7

Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial

Secondary Solid Cancer Following Hematopoietic Cell Transplantation in Patients with Thalassemia Major

Cancer in the National Cancer Institute Inherited Bone Marrow Failure Syndrome Cohort after 15 Years of Follow-up

Anti-Cancer Effects of Clofazimine As a Single Agent and in Combination with Cisplatin in Multiple Myeloma

Risk for New Malignancies of Potential Infectious Etiology Among Adult Survivors of Specific Non-Hodgkin Lymphoma Subtypes

Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012

Rare Presentation of Relapsed Extranasal Natural Killer/T Cell Leukemia Lymphoma Involving the Hypothalamus

National Epidemiology of Venous Thromboembolism in Patients with Malignancy in United States from 1993 to 2012

Prediagnostic Thrombocytosis Increases the Risk of Advanced Gynecological Cancer and Increases Mortality Independently of Cancer Stage – a Population-Based Study

Stem Cell Paradigms in Tissue Regeneration and Cancer

Efficacy and Safety of IV Ferumoxytol (FER) for Iron Deficiency Anemia (IDA) in Patients with Cancer

Primary Granulocytic Sarcoma of Cervix (PGSC): Review and Analysis of 13 Cases

Advanced Age at Transplant Increases the Risk of Second Solid Malignancy (SSM) after Haematopoetic Stem Cell Transplantation (HSCT)

Autoimmune Hemolytic Anemia In Cancer Patients At a Tertiary Center In Southern Nigeria

Expression Patterns Of NBEAL2 In Human Tissues and a Megakaryocytic Cell Line

The Hemostasis and Thrombosis Research Society (HTRS) Registry Study of Acquired Hemophilia: Assessment of AH Patient Demographics in the US

Rates of Malposition and Expulsion of the Levonorgestrel-Releasing Intrauterine System Among Women with Inherited Bleeding Disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only